Anastasia Greenberg, PhD

Senior Associate

Anastasia Greenberg is a senior associate who focuses her practice on a variety of complex intellectual property matters, including prosecution, due diligence and litigation. Dr. Greenberg supports emerging and established clients in the life sciences industry and has handled a wide array of technical matters spanning biologics and medical devices, including macromolecules, antibodies, vaccines, drug delivery systems and molecular diagnostic devices. She has represented clients in patent disputes in district court and the Federal Circuit as well as in post-grant proceedings before the Patent Trial and Appeal Board.

Dr. Greenberg earned her PhD in Neuroscience from the University of Alberta, where she studied mechanisms of applying electrical stimulation to the brain to enhance memory processing. She received a Natural Sciences and Engineering Research Council of Canada Scholarship and a Governor General’s Silver Medal.

Prior to joining WilmerHale, Dr. Greenberg worked as a startup consultant and provided legal and business information on intellectual property, corporate and regulatory matters. She previously worked as a Scientific Review board member for the Branch Out Neurological Foundation and a Google Public Policy Fellow in Washington DC, where she advised policymakers on AI medical devices and submitted regulatory comments to the FDA, among other responsibilities. 


Insights & News


  • Education

    • JD, McGill University, Faculty of Law, 2019

      Dean's Honor List Executive Online Editor, McGill Journal of Law and Health
    • PhD, Neuroscience, University of Alberta, 2016

    • BA, Psychology, York University, 2011

      summa cum laude
  • Admissions

    • Massachusetts

    • US Patent and Trademark Office

  • Languages

    • English

    • French

    • Russian



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.